Published : Dec-2018
No. of Pages : 169
Executive Summary
Overview of Pharmaceutical Market
Overview of Medical Device Market
Deals Analysis
Porter's Five Forces Model
Market Access
Country Healthcare Landscape
Opportunities and Challenges
Appendix
List of Tables
Table 1: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2016 26
Table 2: Medical Device Market, UK, Revenue by Segment ($bn), 2017 46
Table 3: InVitro Diagnostics Devices Market, UK, Revenue and Market Share of Major Players 47
Table 4: Ophthalmic Devices Market, UK, Revenue and Market Share of Major Players 48
Table 5: Cardiovascular Devices Market, UK, Revenue and Market Share of Major Players 49
Table 6: Wound Care Devices Market, UK, Revenue and Market Share of Major Players 50
Table 7: Orthopedic Devices Market, UK, Revenue and Market Share of Major Players 51
Table 8: Market Access, Forecasts and Profile Of Annual Payment Percentages, UK, 2014-2018 94
Table 9: Patent Fees ($), 2018, UK 116
Table 10: Trademark Fees ($), 2018, UK 119
Table 11: Clinical Trials Application Fees ($), 2018, UK 122
Table 12: Clinical Trials Application Fees ($) for Medical Devices, 2018, UK 122
Table 13: Trade Associations, UK 144
Table 14: Trade Fairs, UK 145
List of Figures
Figure 1: Pharmaceutical Market, UK, Revenue, 2015-2022 8
Figure 2: Medical Device Market, UK, Revenue, 2015-2020 8
Figure 3: UK Brexit Timeline, UK, 2018 12
Figure 4: Number of Deals (2017-2018) 14
Figure 5: 2017-2018 Deal Overview By Region 14
Figure 6: Country Profile, UK, 2018 16
Figure 7: Pharmaceutical Market, UK, Revenue, 2010-2017 18
Figure 8: Pharmaceutical Market, UK, Revenue Forecast, 2018-2022 18
Figure 9: Pharmaceutical Market, UK, Pharmaceutical Exports 19
Figure 10: Pharmaceutical Market, UK, Top Export Partners 19
Figure 11: Pharmaceutical Market, UK, Pharmaceutical Imports 20
Figure 12: Pharmaceutical Market, UK, Top Import Partners 20
Figure 13: Pharmaceutical Market, UK, Supply Channels 21
Figure 14: Pharmaceutical Market, UK, Sales of OTC drugs by Major Therapeutic Segments, 2018 25
Figure 15: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class, 2016 26
Figure 16: Pharmaceutical Market, UK, Sales of Patented Drug Products by Major Therapeutic Class ($bn), 2016 26
Figure 17: Pharmaceutical Market, UK, Major Players 28
Figure 18: Medical Device Market, UK, Revenue, 2015-2020 45
Figure 19: Medical Device Market, UK, Revenue Forecast, 2021-2025 45
Figure 20: Medical Device Market, UK, Revenue by Segment, 2017 46
Figure 21: InVitro Diagnostics Devices Market, UK, Revenue 47
Figure 22: InVitro Diagnostics Devices Market, UK, Market Share of Major Players 47
Figure 23: Ophthalmic Devices Market, UK, Revenue 48
Figure 24: Ophthalmic Devices Market, UK, Market Share of Major Players 48
Figure 25: Cardiovascular Devices Market, UK, Revenue 49
Figure 26: Cardiovascular Devices Market, UK, Market Share of Major Players 49
Figure 27: Wound Care Devices Market, UK, Revenue 50
Figure 28: Wound Care Devices Market, UK, Market Share of Major Players 50
Figure 29: Orthopedic Devices Market, UK, Revenue 51
Figure 30: Orthopedic Devices Market, UK, Market Share of Major Players 51
Figure 31: Diagnostic Market, UK, Revenue ($bn), 2015-2020 52
Figure 32: Diagnostic Market, UK, Revenue Forecast ($bn), 2021-2025 52
Figure 33: Medical Device Market, UK, Revenue of Major Players, 2016 54
Figure 34: Deal Value and Deal Count, Pharmaceutical Market, UK, 2017-2018 74
Figure 35: Deal Value and Deal Count Quarterly, Pharmaceutical Market, UK, 2017-2018 74
Figure 36: Deal Value and Deal Count Sub-types, Pharmaceutical Market, UK, 2017-2018 74
Figure 37: Top Five Therapy Area by Deal Value, Pharmaceutical Market, UK, 2017-2018 75
Figure 38: Top Five Therapy Area by Deal Number, Pharmaceutical Market, UK, 2017-2018 75
Figure 39: M&A Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018 75
Figure 40: Venture Financing Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018 75
Figure 41: Private Equity Deals by Therapy Area, Pharmaceutical Market, UK, 2017-2018 75
Figure 42: Medical Device Market Deals, UK, 2017-2018 (by Deal Value, $m) 76
Figure 43: Medical Device Market Deals, UK, 2017- 2018 (by Deal Count) 76
Figure 44: Medical Device Market Deals Share (by Deal Count), UK, 2017-2018 76
Figure 45: Medical Device Market Deals Share (by Deal Value), UK, 2017-2018 76
Figure 46: Medical Device, Top Therapy Area by Deal Value, UK, 2017-2018 77
Figure 47: Medical Device, Top Therapy Area by Deal Number, UK, 2017-2018 77
Figure 48: M&A Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number) 77
Figure 49: Venture Financing Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number) 77
Figure 50: Private Equity Deals by Therapy Area, Medical Device, UK, 2017-2018 (by Value and by Number) 77
Figure 51: Healthcare Market, UK, Overview of Health System, 2018 82
Figure 52: Overview of Finance Flow, UK, 2018 83
Figure 53: NHS Departmental Expenditure Limit ($bn), UK, 2015-2021 84
Figure 54: Market Access, Reimbursement Schemes, UK, 2016 88
Figure 55: OOP Expenditure (% of Total Expenditure on Health), UK, 2010-2017 91
Figure 56: Annual Average Rates of Price Change (%), Medicines Price Index, UK, 2010-2017 91
Figure 57: Market Access, MHRA Structure, UK, 2018 96
Figure 58: Centralized Procedure, UK, 2018 101
Figure 59: Centralized Procedure, EU, 2018 102
Figure 60: Decentralized Procedure, EU, 2018 103
Figure 61: Mutual Recognition Procedure, UK, 2018 104
Figure 62: Life Cycle of Medical Device, UK, 2018 105
Figure 63: Conformity Assessment of Class I Medical Devices, EU, 2018 109
Figure 64: Conformity Assessment of Class IIa Medical Devices, EU, 2018 110
Figure 65: Conformity Assessment of Class IIb Medical Devices, EU, 2018 111
Figure 66: Conformity Assessment of Class III Medical Devices, EU, 2018 112
Figure 67: Licensing Procedure for Pharmaceutical Manufacturing, UK, 2018 113
Figure 68: Patent Approval Process, UK, 2018 115
Figure 69: European Patent Approval Process, EU, 2017 117
Figure 70: Unitary Patent Approval Process, EU, 2017 118
Figure 71: Trademark Approval Process, UK, 2018 119
Figure 72: Clinical Trial Authorization (CTA) Application Flowchart, 2017, UK 121
Figure 73: Market Access, UK, Clinical Trial Regulation Process for Medical Devices, 2018 123
Figure 74: Market Access, Regulatory Changes in the UK Before and After Brexit, 2018 128
Figure 75: Number of Hospitals, UK, 2010-2017 136
Figure 76: Diagnostic Equipment (per Million Population), UK, 2010-2017 136
Figure 77: Hospital Beds (per 1,000 Population), UK 137
Figure 78: Psychiatric Hospital Beds (per 1,000 Population), UK 137
Figure 79: Life Expectancy, 2010-2017, UK 138
Figure 80: Immunization Rate (%), 2010-2017, UK 138
Figure 81: PM2.5 (?g per m3), UK, 2010-2017 139
Figure 82: CO2 Emissions (Million Tons), UK, 2010-2017 139
Figure 83: Physicians (per 1,000 Population), UK, 2010-2016 140
Figure 84: Nurses (per 1,000 Population), UK, 2010-2016 140
Figure 85: Dentists (per 1,000 Population), UK, 2010-2016 140
Figure 86: Pharmacists (per 1,000 Population), UK, 2010-2016 140
Figure 87: Major Causes of Mortality (per 1,000 Population), UK, 2016 141
Figure 88: Major Causes of Male Mortality, UK, 2016 141
Figure 89: Major Causes of Female Mortality, UK, 2016 141
Figure 90: Disability-Adjusted Life Years by Major Disease (000), UK, 2016 141
Figure 91: Healthcare Expenditure as Percentage of GDP (%), UK, 2010-2017 142
Figure 92: Public-Private Share (%), UK, 2010-2017 142
Figure 93: Major Components of Healthcare Spending (%), UK, 2016 143
Figure 94: Opportunities and Challenges, UK 147
